MicroRNA-19 (miR-19) Regulates Tissue Factor Expression in Breast Cancer Cells*
暂无分享,去创建一个
Haijun Yu | Florea Lupu | Jie Zheng | Jie Zheng | J. R. Lou | W. Ding | Hua Zhu | N. Popescu | F. Lupu | Stuart E Lind | S. E. Lind | Wei-Qun Ding | Xiaoxi Zhang | Jessica R Lou | Hua Zhu | Narcis-Ioan Popescu | Haijun Yu | Xiaoxi Zhang | S. Lind | Jessica R. Lou
[1] N. Mackman. Regulation of the Tissue Factor Gene , 1997, Thrombosis and Haemostasis.
[2] E. Furth,et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.
[3] J. Kitzman,et al. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. , 2007, RNA.
[4] J. Rak,et al. The hemostatic system and angiogenesis in malignancy. , 2001, Neoplasia.
[5] M. Reed,et al. Tissue factor, angiogenesis and tumour progression , 2008, Breast Cancer Research.
[6] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[7] E. Izaurralde,et al. Getting to the Root of miRNA-Mediated Gene Silencing , 2008, Cell.
[8] Jie Zhou,et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling , 2010, Proceedings of the National Academy of Sciences.
[9] N. Sangster-Guity,et al. Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment , 2004, Cancer biology & therapy.
[10] S. Coughlin,et al. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Provost,et al. Protein components of the microRNA pathway and human diseases. , 2009, Methods in molecular biology.
[12] D. Tong,et al. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor‐1 in human breast cancer cell lines , 1999, Breast Cancer Research and Treatment.
[13] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[14] S. Linder,et al. Activation of tissue‐factor gene expression in breast carcinoma cells by stimulation of the RAF‐ERK signaling pathway , 1998, Molecular carcinogenesis.
[15] W. Ruf,et al. Tissue factor and PAR2 signaling in the tumor microenvironment. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[16] R. Tsien,et al. Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells , 2002, Science.
[17] M. Ihnat,et al. Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling , 2009, Molecular Pharmacology.
[18] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[19] J. Rak,et al. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy. , 2004, Seminars in thrombosis and hemostasis.
[20] W. Ding,et al. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. , 2004, Molecular cancer therapeutics.
[21] M. Hendrix,et al. Differentially expressed genes associated with the metastatic phenotype in breast cancer , 1999, Breast Cancer Research and Treatment.
[22] Lin Zhang,et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis , 2008, Nature Cell Biology.
[23] N. Tsopanoglou,et al. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. , 2007, Seminars in thrombosis and hemostasis.
[24] Ming-Ta Hsu,et al. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. , 2008, Genome research.
[25] M. Volm,et al. Tissue‐factor expression in human non‐small‐cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis , 1998, International journal of cancer.
[26] J. Steitz,et al. miRNPs: versatile regulators of gene expression in vertebrate cells. , 2009, Biochemical Society transactions.
[27] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[28] S. Nakamura,et al. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration , 2000, British Journal of Cancer.
[29] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[30] Massimo Negrini,et al. Breast cancer metastasis: a microRNA story , 2008, Breast Cancer Research.
[31] Stefanie Dimmeler,et al. Targeting microRNA expression to regulate angiogenesis. , 2008, Trends in pharmacological sciences.
[32] C. Croce,et al. MicroRNA-cancer connection: the beginning of a new tale. , 2006, Cancer research.
[33] T. Miyata,et al. Regulation of human tissue factor expression by mRNA turnover. , 1993, The Journal of biological chemistry.
[34] N. Mackman,et al. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide , 1991, Molecular and cellular biology.
[35] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[36] O. Matsubara,et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis , 1999, British Journal of Cancer.
[37] D. Medina,et al. Re-evaluation of mammary stem cell biology based on in vivo transplantation , 2008, Breast Cancer Research.
[38] G. Hair,et al. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease , 1996, Nature Medicine.
[39] H. Prydz,et al. Coagulation Factors VIIa and Xa Induce Cell Signaling Leading to Up-regulation of the egr-1 Gene* , 1999, The Journal of Biological Chemistry.
[40] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[41] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[42] Terry Hyslop,et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.
[43] K. Picha,et al. CNTO 859, a humanized anti‐tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models , 2007, International journal of cancer.
[44] Xiaofeng Jiang,et al. Formation of tissue factor–factor VIIa–factor Xa complex promotes cellular signaling and migration of human breast cancer cells , 2004, Journal of thrombosis and haemostasis : JTH.
[45] Yuriy Gusev,et al. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. , 2008, Methods.